로딩 중…
지수 로딩 중…
Aprogen, Inc
007460· KOSPI· Industrials· Capital Goods
₩2,795-4.77%
2026-06-19
Price Chart
Aprogen, Inc+315.92%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 65.95B KRW |
| Revenue | 127.54B KRW |
| Net Income | -138.56B KRW |
| Total Assets | 696.52B KRW |
| Net Assets | 430.82B KRW |
| Employees | 296 |
| Value | |
| P/B | 0.15x |
| P/S | 0.52x |
| FCF Yield | -59.60% |
| Profitability | |
| ROE | -32.16% |
| ROA | -19.89% |
| Op. Margin | -73.47% |
| Revenue Growth | 35.79% |
| Financial Health | |
| Debt Ratio | 61.67% |
| Total Debt | 185.58B KRW |
| FCF | -39.30B KRW |
| Cash | 34.54B KRW |
| Current Ratio | 0.85x |
| Performance | |
| 1Y Return | 315.92% |
| 1M Return | -31.24% |
| From 52W High | -64.17% |
| 1Y MDD | -69.23% |
| Trading | |
| Volume | 342,364 shares |
| Foreign Own. | 6.46% |
| Per Share | |
| EPS | -3,403 KRW |
| BPS | 117,663 KRW |
Company Info
Aprogen, established in 1971 and listed in 1995, completed a merger with a biopharmaceutical development company in 2022. Its subsidiary, Aprogen Biologics, formed a biopharmaceutical division in 2022, while N2TEC specializes in semiconductor component manufacturing and sales. Another subsidiary, APTEN, is engaged in geothermal heating/cooling, fuel cells, lithium, brain disease treatment, and virtual asset businesses. The company maintains a diversified business portfolio including hardfacing, steel, pharmaceuticals, insulation, bio, semiconductors, and renewable energy. Aprogen is headquartered in Seongnam-si, Gyeonggi-do.